Physician profile
Shirley Johnson
NPI 1265591952
$2,996.75
in general payments reported to CMS, 2019-2025
17 companies · $91.56 in 2025
The $91.56 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $455 · 2021: $862 · 2022: $395 · 2023: $106 · 2024: $173 · 2025: $91.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,337.60 | 2019-2025 | |
| Redhill Biopharma INC. | $343.01 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.37 | 2019-2024 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $229.80 | 2019-2021 | |
| Pfizer INC. | $215.45 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $214.45 | 2019-2022 | |
| Janssen Biotech, INC. | $118.98 | 2019-2021 | |
| Allergan, INC. | $92.86 | 2019 | |
| Ironwood Pharmaceuticals, INC | $35.79 | 2019-2020 | |
| Genzyme Corporation | $29.63 | 2022 | |
| Merck Sharp & Dohme LLC | $24.56 | 2019-2020 | |
| Ethicon US, LLC | $19.12 | 2019 | |
| Alfasigma USA, INC. | $19.01 | 2021 | |
| Lilly USA, LLC | $17.44 | 2024 | Omvoh |
| Gilead Sciences, INC. | $17.42 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $13.93 | 2019 | |
| Shionogi INC | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.